Stocks · News reference
Bone Biologics shares are trading lower. The company announced that the validated shelf life of its rhNELL-1 protein has been extended to 32 months.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Veeva Systems (NYSE:VEEV) shares increased by 8.7% to $266.15 during Wednesday's after-market session. The market value of their outstanding shares is at $40.0 billion. The company's, Q2 earnings came
Bone Biologics Announces Validated Shelf Life Of rhNELL-1 Protein Extended To 32 Months, Up From 29 Months In May